Editors


Raj Shah

About Raj Shah

Raj Shah has been a member of the InvestorIntel.com team for the last nearly 9 years. Recruited from Merrill Lynch, he has over 13 years’ experience in the capital markets. As a video editor and client care professional he is fast becoming a YouTube expert overseeing InvestorIntel’s YouTube channel which has close to 10,000 subscribers. Additionally, Raj oversees InvestorIntel’s Twitter account and corporate LinkedIn account where InvestorIntel secures over a million impressions a month. A cricket and an online gaming enthusiast, Raj has a Bachelor of Commerce from Sambalpur University. He graduated in 2007 with a First-Class Honors degree.

4259 InvestorIntel Articles By Raj Shah

image_pdfimage_print

Critical Materials Corner with Jack Lifton – Impact of Biden Admin on Rare Earths

In the first episode of the Critical Materials Corner with Jack Lifton, Jack talks about if there is going to […]


Lifton, Clausi, Cashin and Putnam on how the time for scandium is now

The Technology Metals Show hosts Jack Lifton and Peter Clausi talk to Peter Cashin, President and CEO of Imperial Mining […]


Co-founder Thomas Smeenk on the benefits of Hemostemix autologous stem cell therapy

In a recent InvestorIntel interview, Peter Clausi speaks with Thomas Smeenk, Co-Founder, President and CEO of Hemostemix Inc. (TSXV: HEM […]


Peter Clausi with David Morgan on the rising interest in silver for 2021

In a recent InvestorIntel interview, Peter Clausi speaks with David Morgan of The Morgan Report, about investing in silver, the […]


Michael Lende on the rising demand for Predictiv AI’s touchless and non-invasive ThermalPass fever detection system

InvestorIntel’s Peter Clausi speaks with Michael Lende, President and CEO of Predictiv AI Inc. (TSXV: PAI), about the increasing demand […]


Dr Dube and Greg Fenton on ZEN’s potential graphene-based antibiotic, antiviral and antifungal compound

In a recent InvestorIntel interview, Peter Clausi speaks with Dr. Francis Dube, Executive Chairman, and Greg Fenton, CEO and Director […]


Valeo Pharma on a significant upswing with recent Health Canada approvals

In a new InvestorIntel interview Peter Clausi speaks with Steve Saviuk, CEO of Valeo Pharma Inc. (CSE: VPH | OTCQB: […]